Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Ip Group (IPO) Share Price

Price 49.00p on 13-03-2026 at 14:18:12
Change -0.55p -1.11%
Buy 49.10p
Sell 48.90p
Last Trade: Sell 1,924.00 at 49.00p
Day's Volume: 842,011
Last Close: 49.55p
Open: 51.00p
ISIN: GB00B128J450
Day's Range 48.60p - 51.00p
52wk Range: 34.50p - 66.00p
Market Capitalisation: £432.88m
VWAP: 48.84473p
Shares in Issue: 883.43m

Ip Group (IPO) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 1,924 49.00p Automatic Execution
14:18:05 - 13-Mar-26
Sell* 2,226 49.00p Automatic Execution
14:18:05 - 13-Mar-26
Buy* 403 49.05p Automatic Execution
14:18:05 - 13-Mar-26
Sell* 3,124 49.00p Automatic Execution
14:18:05 - 13-Mar-26
Sell* 522 49.00p Automatic Execution
14:18:05 - 13-Mar-26
Buy* 479 49.05p Automatic Execution
14:18:02 - 13-Mar-26
Buy* 461 49.05p Automatic Execution
14:18:02 - 13-Mar-26
Buy* 1,183 49.10p Automatic Execution
14:18:02 - 13-Mar-26
Buy* 1,853 49.10p Automatic Execution
14:18:02 - 13-Mar-26
Buy* 453 49.10p Automatic Execution
14:18:02 - 13-Mar-26
See more Ip Group trades

Ip Group (IPO) Share Price History

Time period:
to
Date Open High Low Close Volume
13th Mar 2026 (Fri) 51.00 51.00 48.60 49.55 842,011
12th Mar 2026 (Thu) 51.00 51.00 49.40 49.55 1,773,983
11th Mar 2026 (Wed) 48.00 50.90 48.00 50.40 1,948,154
10th Mar 2026 (Tue) 52.00 52.00 49.80 50.70 2,378,540
9th Mar 2026 (Mon) 49.00 49.55 48.00 48.65 2,129,787
6th Mar 2026 (Fri) 50.50 50.50 49.45 49.60 3,071,979
5th Mar 2026 (Thu) 53.40 53.40 49.35 49.90 2,012,171
4th Mar 2026 (Wed) 50.00 50.60 48.80 50.40 2,699,039
3rd Mar 2026 (Tue) 51.90 51.90 48.55 49.75 10,634,378
2nd Mar 2026 (Mon) 58.50 58.50 51.80 52.80 3,535,532
27th Feb 2026 (Fri) 55.20 58.40 55.20 57.00 7,627,871
26th Feb 2026 (Thu) 57.10 57.60 56.50 57.50 1,006,160
25th Feb 2026 (Wed) 56.90 57.50 56.50 57.30 948,781
24th Feb 2026 (Tue) 56.80 57.00 55.50 56.00 1,859,013
23rd Feb 2026 (Mon) 57.90 58.30 56.60 56.70 2,580,137
20th Feb 2026 (Fri) 57.50 58.10 57.30 58.00 1,605,213
19th Feb 2026 (Thu) 58.40 58.40 57.60 57.60 2,790,181
18th Feb 2026 (Wed) 60.00 60.00 57.70 58.00 990,877
17th Feb 2026 (Tue) 57.90 58.20 57.60 58.00 771,731
16th Feb 2026 (Mon) 57.70 59.00 57.70 57.80 533,049
13th Feb 2026 (Fri) 57.70 58.90 57.70 58.40 1,047,611
See more Ip Group price history

Ip Group (IPO) Regulatory News

Date Source Headline
12th Mar 2026 11:00 am RNS Holding(s) in Company
12th Mar 2026 9:00 am RNS Notice of Results
12th Mar 2026 9:00 am RNS Notice of Results
4th Mar 2026 7:00 am RNS-R Portfolio company Oxa raises $103m in Series D
26th Feb 2026 2:53 pm RNS Holding(s) in Company
26th Feb 2026 9:30 am RNS Holding(s) in Company
25th Feb 2026 5:51 pm RNS Holding(s) in Company
11th Feb 2026 9:01 am RNS-R Microbiotica announces positive P1b trial results
30th Jan 2026 7:00 am RNS Holding(s) in Company
29th Jan 2026 7:00 am RNS Holding(s) in Company
See more Ip Group regulatory news

Ip Group (IPO) Share News

IP Group commits USD35 million to autonomous driving firm Oxa

4th Mar 2026 11:08

(Alliance News) - Shares in IP Group PLC rose on Wednesday, as the firm noted its participation in a USD103 million fundraise by Oxa Autonomy Ltd. Read More

IN BRIEF: Prudential chair-designate Flint to join insurer on March 4

13th Feb 2026 16:36

Prudential PLC - London-based insurer - Confirms Douglas Flint's appointment as a non-executive director and chair-designate will become effective on March 4. As previously announced, Flint will succeed Shriti Vadera as chair after the annual general meeting on May 28, when Vadera will leave the board. Flint, who has previously chaired Asia-focused lender HSBC Holdings PLC, currently holds the same post at asset manager Aberdeen Group PLC and intellectual property commercialisation firm IP Group PLC. Read More

IP Group portfolio firm Microbiotica reports positive trial results

11th Feb 2026 12:06

(Alliance News) - IP Group PLC on Wednesday said portfolio company Microbiotica Ltd has announced positive results from a phase 1b first-in-human trail of MB310 in ulcerative colitis patients. Read More

Prudential names former HSBC veteran Flint as next chair

14th Jan 2026 06:54

(Alliance News) - Prudential PLC on Wednesday said it has named Douglas Flint as its next chair, replacing Shriti Vadera, who will round off a roughly five-year stint in the position in May. Read More

IN BRIEF: IP Group notes investee Pulmocide terminating phase 3 study

7th Jan 2026 15:20

IP Group PLC - London-based intellectual property commercialisation firm - Notes that portfolio company Pulmocide announced the termination of the Opera-T phase 3 study for opelconazole in refractory invasive pulmonary aspergillosis, a severe fungal infection of the lungs. Opelconazole is an experimental antifungal drug. IP has a 12.0% holding in Pulmocide valued at GBP28.1 million. Pulmocide, a biopharmaceutical firm, will conduct a thorough review of the unblinded data from the trial to determine potential next steps for the programme. IP adds that it expects to "significantly" reduce the carrying value of the asset and conduct further work as part of the year end process to fully gauge the appropriate level of its adjustment. IP says it "benefits from a strong pipeline of new and maturing companies, as well as a number of valuable licences, and remains confident of delivering meaningful returns for shareholders over the medium term." Read More

See more Ip Group news
FTSE 100 Latest
Value10,316.71
Change11.56

Login to your account

Forgot Password?

Not Registered